TableĀ 2

Weaning outcome by primary diagnostic group

n (%)All patients
n=262 (%)
NMD-CWD
n=104 (%)
COPD
n=51 (%)
Postsurgical
n=55 (%)
ORRF
n=14 (%)
Other
n=38 (%)
Self-ventilating100 (38.2)29 (27.9)24 (47.1)27 (49.1)6 (42.9)14 (36.8)
Nocturnal NIV63 (24.0)35 (33.7)9 (17.6)8 (14.5)6 (42.9)5 (13.2)
Nocturnal NIV and daytime use5 (1.9)1 (1.0)0 (0.0)2 (3.6)1 (7.1)1 (2.6)
Long-term tracheostomy56 (21.4)32 (30.8)5 (9.8)8 (14.5)0 (0.0)11 (28.9)
Death38 (14.5)7 (6.7)13 (25.5)10 (18.2)1 (7.1)7 (18.4)
Total weaned168 (64.1)65 (62.5)33 (64.7)37 (67.3)13 (92.9)20 (52.6)
  • COPD, chronic obstructive pulmonary disease; CWD, chest wall disease; NIV, non-invasive ventilation; NMD, neuromuscular disease; ORRF, obesity-related respiratory failure.